Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study

View ORCID ProfileAmal A. Gharamti, Fei Mei, Katherine C. Jankousky, Jin Huang, Peter Hyson, Daniel B. Chastain, Jiawei Fan, Sharmon Osae, Wayne W. Zhang, José G. Montoya, Kristine M. Erlandson, Sias J. Scherger, Carlos Franco-Paredes, View ORCID ProfileAndrés F. Henao-Martínez, Leland Shapiro
doi: https://doi.org/10.1101/2020.10.20.20216309
Amal A. Gharamti
1Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amal A. Gharamti
Fei Mei
2Department of Vascular Surgery, Yichang Central People’s Hospital, The first College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, China
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine C. Jankousky
3Department of Medicine, Anschutz Medical Center Aurora, CO, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Huang
4School of Medicine, Anschutz Medical Center Aurora, CO, USA
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Hyson
3Department of Medicine, Anschutz Medical Center Aurora, CO, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel B. Chastain
5Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, GA, USA
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiawei Fan
2Department of Vascular Surgery, Yichang Central People’s Hospital, The first College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharmon Osae
5Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, GA, USA
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wayne W. Zhang
6Division of Vascular and Endovascular Surgery, Department of Surgery, University of Washington and Puget Sound VA Health Care System, Seattle, WA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José G. Montoya
7Co-director, Dr. Jack S. Remington Laboratory for Specialty Diagnostics, Palo Alto, California
MD, FACP, FIDSA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristine M. Erlandson
8Division of Infectious Diseases, University of Colorado, Anschutz Medical Center Aurora, CO, USA
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sias J. Scherger
8Division of Infectious Diseases, University of Colorado, Anschutz Medical Center Aurora, CO, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Franco-Paredes
8Division of Infectious Diseases, University of Colorado, Anschutz Medical Center Aurora, CO, USA
9Hospital Infantil de México, Federico Gómez, México City, México
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrés F. Henao-Martínez
8Division of Infectious Diseases, University of Colorado, Anschutz Medical Center Aurora, CO, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrés F. Henao-Martínez
  • For correspondence: andres.henaomartinez{at}cuanschutz.edu
Leland Shapiro
8Division of Infectious Diseases, University of Colorado, Anschutz Medical Center Aurora, CO, USA
10Rocky Mountain Regional Veterans Affairs Medical Center, Aurora CO, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance There is a need to develop tools to differentiate COVID-19 from bacterial pneumonia at the time of clinical presentation before diagnostic testing is available.

Objective To determine if the Ferritin-to-Procalcitonin ratio (F/P) can be used to differentiate COVID-19 from bacterial pneumonia.

Design This case-control study compared patients with either COVID-19 or bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumonia co-infection were excluded.

Setting A multicenter study conducted at three hospitals that included UCHealth and Phoebe Putney Memorial Hospital in the United States, and Yichang Central People’s Hospital in China.

Participants A total of 242 cases with COVID-19 infection and 34 controls with bacterial pneumonia.

Main Outcomes and Measures The F/P in patients with COVID-19 or with bacterial pneumonia were compared. Receiver operating characteristic analysis determined the sensitivity and specificity of various cut-off F/P values for the diagnosis of COVID-19 versus bacterial pneumonia.

Results Patients with COVID-19 pneumonia had a lower mean age (57.11 vs 64.4 years, p=0.02) and a higher BMI (30.74 vs 27.15 kg/m2, p=0.02) compared to patients with bacterial pneumonia. Cases and controls had a similar proportion of women (47% vs 53%, p=0.5) and COVID-19 patients had a higher prevalence of diabetes mellitus (32.6% vs 12%, p=0.01). The median F/P was significantly higher in patients with COVID-19 (4037.5) compared to the F/P in bacterial pneumonia (802, p<0.001). An F/P ≥ 877 used to diagnose COVID-19 resulted in a sensitivity of 85% and a specificity of 56%, with a positive predictive value of 93.2%, and a likelihood ratio of 1.92. In multivariable analyses, an F/P ≥ 877 was associated with greater odds of identifying a COVID-19 case (OR: 11.27, CI: 4-31.2, p<0.001).

Conclusions and Relevance An F/P ≥ 877 increases the likelihood of COVID-19 pneumonia compared to bacterial pneumonia. Further research is needed to determine if obtaining ferritin and procalcitonin simultaneously at the time of clinical presentation has improved diagnostic value. Additional questions include whether an increased F/P and/or serial F/P associates with COVID-19 disease severity or outcomes.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Dr. Leland Shapiro is supported by The Emily Foundation. Dr. Erlandson is funded by the National Institute on Aging (AG054366-05S1) and has received research and consultative funds from Gilead Sciences (paid to the University of Colorado).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This investigation was approved by the Colorado Multiple Institutional Review Board (COMIRB) at the University of Colorado Anschutz Medical Campus (UCHealth), the Institutional Review Board (IRB) at Phoebe Putney Memorial Hospital in Albany, Georgia (USA), and the IRB at Yichang Central People Hospital of China Three Gorges University. Clinical data were obtained under a protocol reviewed and approved by IRBs and ethics committees at UCHealth (COMIRB Protocol 20-0690), Phoebe Putney Memorial Hospital (PROJECT00002679), and Yichang Central People Hospital (HEC-KYJJ-2020-026-01).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets used in the current study are available from the corresponding author on a reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 22, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study
Amal A. Gharamti, Fei Mei, Katherine C. Jankousky, Jin Huang, Peter Hyson, Daniel B. Chastain, Jiawei Fan, Sharmon Osae, Wayne W. Zhang, José G. Montoya, Kristine M. Erlandson, Sias J. Scherger, Carlos Franco-Paredes, Andrés F. Henao-Martínez, Leland Shapiro
medRxiv 2020.10.20.20216309; doi: https://doi.org/10.1101/2020.10.20.20216309
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study
Amal A. Gharamti, Fei Mei, Katherine C. Jankousky, Jin Huang, Peter Hyson, Daniel B. Chastain, Jiawei Fan, Sharmon Osae, Wayne W. Zhang, José G. Montoya, Kristine M. Erlandson, Sias J. Scherger, Carlos Franco-Paredes, Andrés F. Henao-Martínez, Leland Shapiro
medRxiv 2020.10.20.20216309; doi: https://doi.org/10.1101/2020.10.20.20216309

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13402)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5181)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4224)
  • Public and Global Health (7526)
  • Radiology and Imaging (1716)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (72)
  • Transplantation (237)
  • Urology (206)